Raymond James & Associates Cooper Companies, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$306.88 - $380.0 $1.01 Million - $1.25 Million	3,298 Added 2.34%	143,961 $54.5 Million
Q3 2023 Oct 24, 2023	BUY	$315.92 - $397.36 $1.06 Million - $1.34 Million	3,368 Added 2.45%	140,663 $44.7 Million
Q2 2023 Jul 25, 2023	BUY	$346.15 - $392.09 $1.01 Million - $1.15 Million	2,922 Added 2.17%	137,295 $52.6 Million
Q1 2023 Apr 14, 2023	BUY	$323.56 - $373.36 $3.01 Million - $3.47 Million	9,297 Added 7.43%	134,373 $50.2 Million
Q4 2022 Feb 08, 2023	BUY	$248.67 - $334.17 $6.58 Million - $8.84 Million	26,449 Added 26.82%	125,076 $41.3 Million
Q3 2022 Oct 25, 2022	BUY	$263.81 - $337.27 $18.4 Million - $23.5 Million	69,697 Added 240.92%	98,627 $26 Million
Q2 2022 Aug 12, 2022	SELL	$301.4 - $428.42 $3.63 Million - $5.15 Million	-12,030 Reduced 29.37%	28,930 $9.06 Million
Q1 2022 May 11, 2022	SELL	$379.46 - $424.54 $37.2 Million - $41.6 Million	-97,973 Reduced 70.52%	40,960 $17.1 Million
Q4 2021 Feb 08, 2022	SELL	$373.53 - $434.12 $5.77 Million - $6.7 Million	-15,438 Reduced 10.0%	138,933 $58.2 Million
Q3 2021 Nov 02, 2021	BUY	$396.76 - $455.92 $2.32 Million - $2.67 Million	5,856 Added 3.94%	154,371 $63.8 Million
Q2 2021 Aug 11, 2021	BUY	$372.36 - $412.07 $4.44 Million - $4.91 Million	11,913 Added 8.72%	148,515 $58.9 Million
Q1 2021 May 14, 2021	BUY	$357.26 - $392.57 $3.86 Million - $4.25 Million	10,818 Added 8.6%	136,602 $52.5 Million
Q4 2020 Feb 12, 2021	BUY	$319.05 - $363.32 $3.2 Million - $3.64 Million	10,023 Added 8.66%	125,784 $45.7 Million
Q3 2020 Nov 04, 2020	BUY	$280.08 - $347.78 $6.85 Million - $8.51 Million	24,474 Added 26.81%	115,761 $39 Million
Q2 2020 Jul 28, 2020	BUY	$270.93 - $320.3 $1.87 Million - $2.21 Million	6,900 Added 8.18%	91,287 $25.9 Million
Q1 2020 Apr 21, 2020	BUY	$243.44 - $359.98 $4.23 Million - $6.25 Million	17,359 Added 25.9%	84,387 $23.3 Million
Q4 2019 Feb 12, 2020	BUY	$281.18 - $322.05 $2.77 Million - $3.17 Million	9,848 Added 17.22%	67,028 $21.5 Million
Q3 2019 Nov 07, 2019	BUY	$294.25 - $341.49 $569,373 - $660,783	1,935 Added 3.5%	57,180 $17 Million
Q2 2019 Aug 06, 2019	BUY	$279.29 - $336.89 $2.61 Million - $3.15 Million	9,348 Added 20.37%	55,245 $18.6 Million
Q1 2019 May 06, 2019	BUY	$246.18 - $297.25 $1.18 Million - $1.43 Million	4,805 Added 11.69%	45,897 $13.6 Million
Q4 2018 Feb 11, 2019	BUY	$232.7 - $281.66 $1.26 Million - $1.52 Million	5,412 Added 15.17%	41,092 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$236.3 - $277.15 $3.6 Million - $4.22 Million	15,233 Added 74.5%	35,680 $9.89 Million
Q2 2018 Aug 14, 2018	SELL	$217.98 - $237.23 $3.48 Million - $3.79 Million	-15,956 Reduced 43.83%	20,447 $4.81 Million
Q1 2018 May 14, 2018	BUY	$218.74 - $251.43 $129,931 - $149,349	594 Added 1.66%	36,403 $8.33 Million
Q4 2017 Feb 14, 2018	BUY	$217.88 - $244.43 $3.01 Million - $3.38 Million	13,824 Added 62.88%	35,809 $7.8 Million
Q3 2017 Nov 13, 2017	BUY	$231.6 - $253.39 $58,131 - $63,600	251 Added 1.15%	21,985 $5.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,734	21,734 $5.2 Million

Others Institutions Holding COO

# of Institutions

Shares Held

1.59M

Call Options Held

Put Options Held

Intermede Investment Partners LTD

1.09M
Shares

$109 Million
2.52% of portfolio
Pictet Asset Management Sa Geneva 73, V8

143K
Shares

$14.2 Million
0.07% of portfolio
Brant Point Investment Management LLC New York, NY

109K
Shares

$10.9 Million
2.96% of portfolio
Eaton Vance Management Boston, MA

86.1K
Shares

$8.58 Million
0.03% of portfolio
Crystal Rock Capital Management

54.2K
Shares

$5.4 Million
3.65% of portfolio

View Full List

About COOPER COMPANIES, INC.

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

More about COO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account